Medaphor Group PLC ScanTrainer at Central Middlesex Hospital
07 June 2018 - 4:01PM
RNS Non-Regulatory
TIDMMED
Medaphor Group PLC
07 June 2018
7 June 2018
MedaPhor Group plc
("MedaPhor" or the "Group" or the "Company")
ScanTrainer installed at Central Middlesex Hospital
MedaPhor Group plc (AIM: MED), the intelligent ultrasound
software and simulation company, announces that ScanTrainer, the
OBGYN and General Medical simulator training platform, has been
installed at a new Ultrasound Training Academy at Central Middlesex
Hospital, London, UK.
The London North West Healthcare NHS Trust (LNWH) has chosen
ScanTrainer for its new state-of-the-art ultrasound education
facility based at Central Middlesex Hospital. The Academy has been
designed to ease growing ultrasound training pressures and clinical
demands across the Trust and beyond.
Following an assessment of the ultrasound simulation market, the
Trust purchased a ScanTrainer Transvaginal Simulator (TVS) and a
ScanTrainer Transabdominal Simulator (TAS) to support the Trust in
making training more accessible for those learning and improving
their ultrasound skills.
Tanuja Khiroya, Clinical Lead Radiology & Medical Physics,
at Central Middlesex Hospital, who pioneered and led the project,
commented: "Historically ultrasound trainees would have completed
the bulk of their learning in the clinic or by using text books.
ScanTrainer represents a step-change by enabling clinicians to
learn independently in a patient-safe environment before practising
on patients. This ensures that trainees are not only acquiring
skills faster but are well equipped and confident when it comes to
scanning real patients for the first time."
Ian Whittaker, Chief Operating Officer, at MedaPhor, said: "We
have seen the emergence of a number of ultrasound academies across
the UK recently with Norwich, Leeds, Peninsula, Wales and, of
course, Central Middlesex being some of the pioneers in this space.
It's very encouraging to see ultrasound skills initiatives such as
these taking strides to close the skills gap and MedaPhor is
delighted to be able to equip them with simulation technologies
that can help them achieve their goals."
MedaPhor Group plc www.medaphor.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Ian Whittaker, COO
Cenkos Securities Tel: +44 (0)20 7397 8900
Camilla Hume (Nominated Advisor)
Michael Johnson / Julian Morse (Corporate
Broking)
Walbrook PR Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com
Paul McManus / Anna Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741
Dunphy 001
About MedaPhor (www.investors.medaphor.com)
MedaPhor (AIM: MED), the intelligent ultrasound software and
simulation company, develops artificial intelligence-based clinical
image analysis software tools, augmented reality-based needle
guidance software and advanced hi-fidelity haptic and manikin-based
training simulators for medical practitioners.
Based in Cardiff and Oxford in the UK, Atlanta in the US and
Hong Kong in Asia, MedaPhor operates two divisions:
Intelligent Ultrasound Simulation Division
Focuses on hi-fidelity ultrasound education and training through
simulation. Its three main products are the ScanTrainer OBGYN and
General Medical simulator training platform, the HeartWorks
echocardiography simulator platform and the BodyWorks Eve Point of
Care and Emergency Medicine Simulator. Over 500 MedaPhor simulators
have been sold to over 300 medical institutions in over 30
countries around the world.
Intelligent Ultrasound Clinical Division
Focuses on augmented reality and deep-learning based algorithms
to make ultrasound machines smarter and more accessible. Products
in development include ScanNav and NeedleGuide. ScanNav uses
machine-learning based algorithms to automatically identify, grade
and capture good ultrasound images. NeedleGuide aims to simplify
ultrasound-guided needling by using deep learning and augmented
reality to provide the user with pathway guidance and automated
tracking for a range of medical procedures.
Some products in the pipeline may require US FDA approval, as
such this material should be considered informational only and does
not constitute an offer to sell or infer claims or benefits.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAEASKKEDSPEFF
(END) Dow Jones Newswires
June 07, 2018 02:01 ET (06:01 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Apr 2024 to May 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From May 2023 to May 2024